The short answer: perimenopausal symptoms are rarely random, and treating each one in isolation (a sleep tablet for insomnia, an antihistamine for new allergies, a painkiller for joint aches) often gives short-term relief while missing the underlying physiology. Symptoms reflect shifts in the body’s neuroendocrine axes and in foundational systems such as the gut, thyroid, stress response and nutrient status. When those systems are already under strain, the body has less resilience to the hormonal fluctuations of perimenopause, and symptoms feel amplified and more persistent. Stepping back to take an aerial, whole-system view of what is driving the symptoms, rather than firefighting them one at a time, tends to produce better and more sustainable results.
Perimenopause is the transitional phase leading up to menopause, often beginning in the mid-to-late 30s or 40s, during which ovarian hormone production becomes increasingly erratic before declining more steadily. Many women experience a wide range of symptoms: hot flushes, night sweats, sleep disturbance, mood changes, brain fog, heavier or irregular bleeding, palpitations, joint pain, changes in skin and hair, and shifts in weight or body composition. It is common to feel as though you are “fighting fires” one symptom at a time, yet still not getting lasting relief. In clinical practice, we often see better and more sustainable outcomes when we step back from isolated symptom management and instead take an aerial, whole-system view of what is driving those symptoms in the first place.
Why symptom-by-symptom approaches often fall short
Treating each symptom in isolation, sleep tablets for insomnia, antihistamines for new-onset allergies, painkillers for joint aches, antidepressants for low mood, can provide short-term relief but may miss the underlying physiology. Perimenopausal symptoms are not random; they reflect shifts in neuroendocrine axes (HPO, HPA, HPT), changes in metabolism and inflammation, and alterations in key systems such as the gut, thyroid, and nutrient status. When these foundational systems are suboptimal, the body has less resilience to the hormonal fluctuations of perimenopause, and symptoms can feel amplified and more persistent.
At The Nadura clinic, the clients who tend to struggle most through perimenopause are often those who already had subtle or overt dysregulation in these areas in the 5 to 10 years before their cycles began to change. Addressing these root contributors does not mean ignoring symptoms; it means creating a physiological environment in which symptoms are less likely to escalate and are easier to manage when they do arise.
The gut–hormone axis: why gut health is central in perimenopause
The gut is sometimes called the “second brain,” but in the context of hormones it might more accurately be described as an “oestrogen clearance organ.” A specialised subset of gut microbes, collectively termed the oestrobolome, produces enzymes such as β-glucuronidase that influence how oestrogen is metabolised, recirculated, and excreted. When the gut microbiome is diverse and balanced, oestrogen metabolism tends to be more efficient; when there is dysbiosis (an imbalance in microbial species), oestrogen clearance can become erratic, contributing to both oestrogen-dominant and oestrogen-deficient symptom patterns.
Perimenopause itself is associated with shifts in gut microbial diversity and function, and these shifts can in turn influence inflammation, mood, sleep, vasomotor symptoms, weight distribution and bone health. Women with greater microbial diversity tend to show more favourable oestrogen regulation and fewer inflammatory biomarkers during the menopausal transition. Conversely, reduced diversity and altered microbial ratios have been linked to higher inflammatory markers and more severe perimenopausal symptoms.
Clinically, this means that gut symptoms (bloating, irregular bowels, reflux, food intolerances, recurrent thrush or UTIs, skin issues) are not just “digestive problems”; they are often part of the hormonal picture. Supporting gut integrity, microbial balance and regular elimination can be a powerful lever for stabilising oestrogen metabolism and reducing the overall symptom load in perimenopause.
Thyroid function: the quiet driver behind many perimenopausal symptoms
Thyroid hormones interact closely with reproductive hormones through the hypothalamic–pituitary–thyroid (HPT) and hypothalamic–pituitary–ovarian (HPO) axes. Thyroid dysfunction, especially subclinical hypothyroidism or autoimmune thyroiditis, can mimic or magnify perimenopausal symptoms such as fatigue, weight gain, hair loss, dry skin, low mood, anxiety, brain fog, and menstrual irregularity. Research shows that HPT axis dysfunction is closely related to depression and anxiety in perimenopausal women, and that thyroid hormones indirectly influence reproductive function via effects on gonadotropin-releasing hormone (GnRH) and oestrogen levels.
Because thyroid and ovarian hormones share regulatory pathways, a borderline or under-treated thyroid issue can make perimenopause feel significantly worse. In practice, we often see women whose “perimenopause” improves markedly once thyroid function is optimised, even if their thyroid labs were previously considered “within range” but not optimal for their physiology.
Chronic stress and HPA axis dysregulation: setting the stage before perimenopause
The hypothalamic–pituitary–adrenal (HPA) axis governs the body’s stress response and interacts bidirectionally with reproductive and thyroid axes. Chronic stress, whether from work, caregiving, illness, pain, sleep deprivation, or emotional strain, can lead to HPA axis dysregulation, characterised by altered cortisol rhythms, heightened inflammatory tone and changes in neurotransmitter balance.
Research indicates that HPA axis activation tends to increase from early to late menopause, with rising cortisol and glucocorticoid production over time. While the direct causal role of HPA dysregulation in perimenopausal depression remains debated, there is clear evidence that HPA hyperactivity can inhibit HPO axis function and contribute to reproductive dysfunction, including irregular cycles and altered ovulation. In clinical practice, many women who report severe perimenopausal symptoms have a history of long-standing stress, poor sleep, overtraining, under-eating, or chronic health issues that have kept their HPA axis on high alert for years before their cycles begin to change.
This matters because a dysregulated HPA axis reduces physiological resilience: the same hormonal fluctuations that might have been manageable in your 30s can feel overwhelming in your 40s when your stress-response system is already overloaded. Supporting HPA axis function, through sleep, nutrition, movement, nervous-system regulation and targeted supplementation, often makes perimenopausal symptoms more tractable and less intense.
Frequently Asked Questions
Why doesn’t treating perimenopause symptoms one at a time work well?
Treating each symptom in isolation, such as sleep tablets for insomnia or painkillers for joint aches, can give short-term relief but often misses the underlying physiology. Perimenopausal symptoms reflect shifts in the body’s neuroendocrine axes and in systems like the gut, thyroid and stress response. When those foundations are strained, symptoms are amplified, so addressing the root contributors tends to give more lasting relief.
How is gut health connected to perimenopause hormones?
A subset of gut microbes, called the oestrobolome, produces enzymes that influence how oestrogen is metabolised, recirculated and excreted. When the microbiome is diverse and balanced, oestrogen metabolism tends to be more efficient; when it is imbalanced, oestrogen clearance can become erratic. This is why gut symptoms like bloating, irregular bowels or recurrent thrush are often part of the hormonal picture, not just digestive issues.
Can thyroid problems make perimenopause worse?
Yes. Thyroid and ovarian hormones share regulatory pathways, so thyroid dysfunction, especially subclinical hypothyroidism or autoimmune thyroiditis, can mimic or magnify perimenopausal symptoms such as fatigue, weight gain, brain fog, low mood and menstrual irregularity. A borderline or under-treated thyroid issue can make the transition feel significantly harder, and optimising thyroid function often improves how women feel.
How does chronic stress affect perimenopause?
Long-standing stress can dysregulate the HPA axis, altering cortisol rhythms and raising inflammatory tone. HPA activation tends to increase from early to late menopause, and HPA hyperactivity can inhibit ovarian function and contribute to irregular cycles. A dysregulated stress-response system reduces resilience, so the same hormonal fluctuations that felt manageable in your 30s can feel overwhelming in your 40s.
What is a whole-system or root-cause approach to perimenopause?
It means stepping back from isolated symptom management to look at the foundational systems driving symptoms: the gut, thyroid, stress response and nutrient status. In practice this involves a detailed history of the years before your cycles changed, targeted functional testing, and a personalised nutrition and lifestyle plan. The aim is to create a physiological environment in which symptoms are less likely to escalate.
Can a whole-system approach be used alongside HRT?
Yes. A functional, root-cause approach is designed to work alongside any medical care you are receiving, including HRT. The idea is that lifestyle, nutrition and medical care all pull in the same direction, working with your GP, gynaecologist or HRT prescriber rather than replacing them.
Further Reading & Sources
The research referenced in this article draws on the following peer-reviewed sources:
- Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen–gut microbiome axis: physiological and clinical implications. Maturitas, 2017. Read the paper
- Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes, 2023. Read the paper
- Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk. mSystems, 2022. Read the paper
- European Menopause and Andropause Society (EMAS) position statement: Thyroid disease and menopause. Maturitas, 2024. Read the paper
- Prevalence of anxiety and depressive symptoms among patients with hypothyroidism. 2016. Read the paper
- Gordon JL, Girdler SS, et al. Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression. American Journal of Psychiatry, 2015. Read the paper
- Steroid hormone secretion over the course of the perimenopause (Swiss Perimenopause Study). Frontiers in Global Women’s Health, 2021. Read the paper
This article is contributed by an external practitioner and is for general information only; it does not constitute medical advice, diagnosis, or a recommendation to start, stop or change any treatment, including HRT. Always consult a qualified healthcare professional about your individual circumstances.

